Pancreatic Cancer Research

ResearcherUniversity of CopenhagenActive in the last 2 years

Peter Vilmann

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7889-1104; OpenAlex author ID A5055818241, A5108105199. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
41
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 8

  1. Regulatory elements in the Sox9 locus license the initiation of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.celrep.2026.117176↗
  2. Preoperative EUS-guided biopsy does not affect survival in patients with pancreatic cancer: A nationwide cohort study. Last author DOI 10.1097/eus.0000000000000156↗
  3. EUS-guided biopsies versus surgical specimens for establishing patient-derived pancreatic cancer organoids: a systematic review and meta-analysis. Co-author DOI 10.1016/j.gie.2024.04.012↗
  4. Validation of a Novel EUS-FNB-Derived Organoid Co-Culture System for Drug Screening in Patients with Pancreatic Cancer. Co-author DOI 10.3390/cancers15143677↗
  5. Changes in tumor vascularity depicted by contrast-enhanced EUS as a predictor of prognosis and treatment efficacy in patients with unresectable pancreatic canc… Co-author DOI 10.4103/eus.eus_16_19↗
  6. The role of contrast-enhanced endoscopic ultrasound in pancreatic adenocarcinoma. First author DOI 10.4103/2303-9027.190932↗
  7. [Endoscopic ultrasound-guided coeliac plexus neurolysis to reduce pain in patients with pancreatic cancer]. Last author PMID 25498187↗
  8. Feasibility study of EUS-NOTES as a novel approach for pancreatic cancer staging and therapy: an international collaborative study. Co-author DOI 10.5754/hge11774↗

Closest collaborators

The 25 strongest of 41 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bojan Kovacevic · 3 shared papers, 2023–2025 · strength 0.66
  2. Pia Helene Klausen · 3 shared papers, 2023–2026 · strength 0.64
  3. Simon Ezban Grützmeier · 2 shared papers, 2023–2024 · strength 0.41
  4. Carsten Palnæs Hansen · 2 shared papers, 2023–2025 · strength 0.41
  5. Frank Viborg Mortensen · 1 shared paper, 2025 · strength 0.26
  6. Claus Wilki Fristrup · 1 shared paper, 2025 · strength 0.26
  7. Mogens Tornby Stender · 1 shared paper, 2025 · strength 0.26
  8. Jakob Kirkegård · 1 shared paper, 2025 · strength 0.26
  9. Michael Bau Mortensen · 1 shared paper, 2025 · strength 0.26
  10. Sönke Detlefsen · 1 shared paper, 2025 · strength 0.26
  11. Marta Ballester · 1 shared paper, 2026 · strength 0.23
  12. Elisa Espinet · 1 shared paper, 2026 · strength 0.23
  13. H. Carlo Maurer · 1 shared paper, 2026 · strength 0.23
  14. Luís Arnes · 1 shared paper, 2026 · strength 0.23
  15. Albin Sandelin · 1 shared paper, 2026 · strength 0.23
  16. Manoop S. Bhutani · 3 shared papers, 2013–2019 · strength 0.20
  17. Adrian Săftoiu · 3 shared papers, 2013–2019 · strength 0.20
  18. Hanne Grossjohann · 1 shared paper, 2023 · strength 0.15
  19. Estrid Vilma Solyom Høgdall · 1 shared paper, 2023 · strength 0.15
  20. JulioIglesias Garcia · 1 shared paper, 2019 · strength 0.07
  21. Michael Hocke · 1 shared paper, 2019 · strength 0.07
  22. Mariana Jinga · 1 shared paper, 2019 · strength 0.07
  23. ChristophF Dietrich · 1 shared paper, 2019 · strength 0.07
  24. Alina Liliana Constantin · 1 shared paper, 2019 · strength 0.07
  25. Irina Mihaela Cazacu · 1 shared paper, 2019 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.